<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38392604</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-4426</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Jan</Month><Day>31</Day></PubDate></JournalIssue><Title>Journal of personalized medicine</Title><ISOAbbreviation>J Pers Med</ISOAbbreviation></Journal><ArticleTitle>Possible Role of Fibrinaloid Microclots in Postural Orthostatic Tachycardia Syndrome (POTS): Focus on Long COVID.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">170</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jpm14020170</ELocationID><Abstract><AbstractText>Postural orthostatic tachycardia syndrome (POTS) is a common accompaniment of a variety of chronic, inflammatory diseases, including long COVID, as are small, insoluble, 'fibrinaloid' microclots. We here develop the argument, with accompanying evidence, that fibrinaloid microclots, through their ability to block the flow of blood through microcapillaries and thus cause tissue hypoxia, are not simply correlated with but in fact, by preceding it, may be a chief intermediary cause of POTS, in which tachycardia is simply the body's exaggerated 'physiological' response to hypoxia. Similar reasoning accounts for the symptoms bundled under the term 'fatigue'. Amyloids are known to be membrane disruptors, and when their targets are nerve membranes, this can explain neurotoxicity and hence the autonomic nervous system dysfunction that contributes to POTS. Taken together as a system view, we indicate that fibrinaloid microclots can serve to link POTS and fatigue in long COVID in a manner that is at once both mechanistic and explanatory. This has clear implications for the treatment of such diseases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kell</LastName><ForeName>Douglas B</ForeName><Initials>DB</Initials><Identifier Source="ORCID">0000-0001-5838-7963</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry, Cell and Systems Biology, Institute of Systems, Molecular and Integrative Biology, Faculty of Health and Life Sciences, University of Liverpool, Crown St, Liverpool L69 7ZB, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Novo Nordisk Foundation Centre for Biosustainability, Building 220, Chemitorvet 200, Technical University of Denmark, 2800 Kongens Lyngby, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiological Sciences, Faculty of Science, Stellenbosch University, Stellenbosch Private Bag X1, Matieland 7602, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Muhammed Asad</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0003-1838-9002</Identifier><AffiliationInfo><Affiliation>Directorate of Respiratory Medicine, Manchester University Hospitals, Wythenshawe Hospital, Manchester M23 9LT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kane</LastName><ForeName>Binita</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Cell and Systems Biology, Institute of Systems, Molecular and Integrative Biology, Faculty of Health and Life Sciences, University of Liverpool, Crown St, Liverpool L69 7ZB, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Manchester University Foundation Trust and School of Biological Sciences, University of Manchester, Manchester M13 9PL, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lip</LastName><ForeName>Gregory Y H</ForeName><Initials>GYH</Initials><Identifier Source="ORCID">0000-0002-7566-1626</Identifier><AffiliationInfo><Affiliation>Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart &amp; Chest Hospital, Liverpool L14 3PE, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Danish Center for Health Services Research, Department of Clinical Medicine, Aalborg University, 9220 Aalborg, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pretorius</LastName><ForeName>Etheresia</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-9108-2384</Identifier><AffiliationInfo><Affiliation>Department of Biochemistry, Cell and Systems Biology, Institute of Systems, Molecular and Integrative Biology, Faculty of Health and Life Sciences, University of Liverpool, Crown St, Liverpool L69 7ZB, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiological Sciences, Faculty of Science, Stellenbosch University, Stellenbosch Private Bag X1, Matieland 7602, South Africa.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>142142</GrantID><Agency>National Research Foundation</Agency><Country/></Grant><Grant><GrantID>NNF10CC1016517</GrantID><Agency>Novo Nordisk Foundation</Agency><Country/></Grant><Grant><GrantID>SIR grant</GrantID><Agency>South African Medical Research Council</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Pers Med</MedlineTA><NlmUniqueID>101602269</NlmUniqueID><ISSNLinking>2075-4426</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">TeamClots</Keyword><Keyword MajorTopicYN="N">fibrinaloid microclots</Keyword><Keyword MajorTopicYN="N">postural orthostatic tachycardia syndrome (POTS)</Keyword></KeywordList><CoiStatement>E.P. is a named inventor on a patent application covering the use of fluorescence methods for microclot detection in long COVID.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>1</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>23</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>23</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>23</Day><Hour>10</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38392604</ArticleId><ArticleId IdType="pmc">PMC10890060</ArticleId><ArticleId IdType="doi">10.3390/jpm14020170</ArticleId><ArticleId IdType="pii">jpm14020170</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Niemitz C. The evolution of the upright posture and gait&#x2014;A review and a new synthesis. Naturwissenschaften. 2010;97:241&#x2013;263. doi: 10.1007/s00114-009-0637-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00114-009-0637-3</ArticleId><ArticleId IdType="pmc">PMC2819487</ArticleId><ArticleId IdType="pubmed">20127307</ArticleId></ArticleIdList></Reference><Reference><Citation>Freeman R., Wieling W., Axelrod F.B., Benditt D.G., Benarroch E., Biaggioni I., Cheshire W.P., Chelimsky T., Cortelli P., Gibbons C.H., et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Auton. Neurosci. 2011;161:46&#x2013;48. doi: 10.1016/j.autneu.2011.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2011.02.004</ArticleId><ArticleId IdType="pubmed">21393070</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedorowski A. Postural orthostatic tachycardia syndrome: Clinical presentation, aetiology and management. J. Intern. Med. 2019;285:352&#x2013;366. doi: 10.1111/joim.12852.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.12852</ArticleId><ArticleId IdType="pubmed">30372565</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernino S., Bourne K.M., Stiles L.E., Grubb B.P., Fedorowski A., Stewart J.M., Arnold A.C., Pace L.A., Axelsson J., Boris J.R., et al. Postural orthostatic tachycardia syndrome (POTS): State of the science and clinical care from a 2019 national institutes of health expert consensus meeting&#x2014;Part 1. Auton. Neurosci. 2021;235:102828. doi: 10.1016/j.autneu.2021.102828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2021.102828</ArticleId><ArticleId IdType="pmc">PMC8455420</ArticleId><ArticleId IdType="pubmed">34144933</ArticleId></ArticleIdList></Reference><Reference><Citation>Grubb A.F., Grubb B.P. Postural orthostatic tachycardia syndrome: New concepts in pathophysiology and management. Trends Cardiovasc. Med. 2023;33:65&#x2013;69. doi: 10.1016/j.tcm.2021.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcm.2021.10.007</ArticleId><ArticleId IdType="pubmed">34695573</ArticleId></ArticleIdList></Reference><Reference><Citation>Schondorf R., Low P.A. Idiopathic postural orthostatic tachycardia syndrome: An attenuated form of acute pandysautonomia? Neurology. 1993;43:132&#x2013;137. doi: 10.1212/WNL.43.1_Part_1.132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.43.1_Part_1.132</ArticleId><ArticleId IdType="pubmed">8423877</ArticleId></ArticleIdList></Reference><Reference><Citation>Safavi-Naeini P., Razavi M. Postural orthostatic tachycardia syndrome. Tex. Heart Inst. J. 2020;47:57&#x2013;59. doi: 10.14503/THIJ-19-7060.</Citation><ArticleIdList><ArticleId IdType="doi">10.14503/THIJ-19-7060</ArticleId><ArticleId IdType="pmc">PMC7046364</ArticleId><ArticleId IdType="pubmed">32148459</ArticleId></ArticleIdList></Reference><Reference><Citation>Bryarly M., Phillips L.T., Fu Q., Vernino S., Levine B.D. Postural orthostatic tachycardia syndrome: JACC focus seminar. J. Am. Coll. Cardiol. 2019;73:1207&#x2013;1228. doi: 10.1016/j.jacc.2018.11.059.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2018.11.059</ArticleId><ArticleId IdType="pubmed">30871704</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw B.H., Stiles L.E., Bourne K., Green E.A., Shibao C.A., Okamoto L.E., Garland E.M., Gamboa A., Diedrich A., Raj V., et al. The face of postural tachycardia syndrome&#x2014;Insights from a large cross-sectional online community-based survey. J. Intern. Med. 2019;286:438&#x2013;448. doi: 10.1111/joim.12895.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.12895</ArticleId><ArticleId IdType="pmc">PMC6790699</ArticleId><ArticleId IdType="pubmed">30861229</ArticleId></ArticleIdList></Reference><Reference><Citation>Lecheler L., Hoffmann F., Tank J., Jordan J. Run vagus run: Cardiovagal baroreflex function and the postural tachycardia syndrome. Hypertension. 2021;77:1245&#x2013;1247. doi: 10.1161/HYPERTENSIONAHA.121.16578.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.121.16578</ArticleId><ArticleId IdType="pubmed">33689465</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal A.K., Garg R., Ritch A., Sarkar P. Postural orthostatic tachycardia syndrome. Postgrad. Med. J. 2007;83:478&#x2013;480. doi: 10.1136/pgmj.2006.055046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/pgmj.2006.055046</ArticleId><ArticleId IdType="pmc">PMC2600095</ArticleId><ArticleId IdType="pubmed">17621618</ArticleId></ArticleIdList></Reference><Reference><Citation>Low P.A., Sandroni P., Joyner M., Shen W.K. Postural tachycardia syndrome (POTS) J. Cardiovasc. Electrophysiol. 2009;20:352&#x2013;358. doi: 10.1111/j.1540-8167.2008.01407.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1540-8167.2008.01407.x</ArticleId><ArticleId IdType="pmc">PMC3904426</ArticleId><ArticleId IdType="pubmed">19207771</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamrefors V., Spahic J.M., Nilsson D., Senneby M., Sutton R., Melander O., Fedorowski A. Syndromes of orthostatic intolerance and syncope in young adults. Open Heart. 2017;4:e000585. doi: 10.1136/openhrt-2016-000585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/openhrt-2016-000585</ArticleId><ArticleId IdType="pmc">PMC5471871</ArticleId><ArticleId IdType="pubmed">28674628</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold A.C., Ng J., Raj S.R. Postural tachycardia syndrome&#x2014;Diagnosis, physiology, and prognosis. Auton. Neurosci. 2018;215:3&#x2013;11. doi: 10.1016/j.autneu.2018.02.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2018.02.005</ArticleId><ArticleId IdType="pmc">PMC6113123</ArticleId><ArticleId IdType="pubmed">29523389</ArticleId></ArticleIdList></Reference><Reference><Citation>Hassani M., Fathi Jouzdani A., Motarjem S., Ranjbar A., Khansari N. How COVID-19 can cause autonomic dysfunctions and postural orthostatic syndrome? A review of mechanisms and evidence. Neurol. Clin. Neurosci. 2021;9:434&#x2013;442. doi: 10.1111/ncn3.12548.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ncn3.12548</ArticleId><ArticleId IdType="pmc">PMC8661735</ArticleId><ArticleId IdType="pubmed">34909198</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Rhermoul F.Z., Fedorowski A., Eardley P., Taraborrelli P., Panagopoulos D., Sutton R., Lim P.B., Dani M. Autoimmunity in long COVID and POTS. Oxf. Open Immunol. 2023;4:iqad002. doi: 10.1093/oxfimm/iqad002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfimm/iqad002</ArticleId><ArticleId IdType="pmc">PMC10224806</ArticleId><ArticleId IdType="pubmed">37255928</ArticleId></ArticleIdList></Reference><Reference><Citation>Blitshteyn S., Whiteson J., Abramoff B.A., Azola A., Bartels M.N., Bhavaraju-Sanka R., Chung T., Fleming T.K., Henning E., Miglis M.G., et al. Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of autonomic dysfunction in patients with post-acute sequelae of SARS-CoV-2 infection (PASC) PM&amp;R. 2022;14:1270&#x2013;1291. doi: 10.1002/pmrj.12894.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmrj.12894</ArticleId><ArticleId IdType="pmc">PMC9538426</ArticleId><ArticleId IdType="pubmed">36169154</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallick D., Goyal L., Chourasia P., Zapata M.R., Yashi K., Surani S. COVID-19 induced postural orthostatic tachycardia syndrome (POTS): A review. Cureus. 2023;15:e36955. doi: 10.7759/cureus.36955.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.36955</ArticleId><ArticleId IdType="pmc">PMC10065129</ArticleId><ArticleId IdType="pubmed">37009342</ArticleId></ArticleIdList></Reference><Reference><Citation>Narasimhan B., Calambur A., Moras E., Wu L., Aronow W. Postural orthostatic tachycardia syndrome in COVID-19: A contemporary review of mechanisms, clinical course and management. Vasc. Health Risk Manag. 2023;19:303&#x2013;316. doi: 10.2147/VHRM.S380270.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/VHRM.S380270</ArticleId><ArticleId IdType="pmc">PMC10187582</ArticleId><ArticleId IdType="pubmed">37204997</ArticleId></ArticleIdList></Reference><Reference><Citation>Pollack B., von Saltza E., McCorkell L., Santos L., Hultman A., Cohen A.K., Soares L. Female reproductive health impacts of long COVID and associated illnesses including ME/CFS, POTS, and connective tissue disorders: A literature review. Front. Rehabil. Sci. 2023;4:1122673. doi: 10.3389/fresc.2023.1122673.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fresc.2023.1122673</ArticleId><ArticleId IdType="pmc">PMC10208411</ArticleId><ArticleId IdType="pubmed">37234076</ArticleId></ArticleIdList></Reference><Reference><Citation>St&#xe5;hlberg M., Mahdi A., Johansson M., Fedorowski A., Olshansky B. Cardiovascular dysautonomia in postacute sequelae of SARS-CoV-2 infection. J. Cardiovasc. Electrophysiol. 2023. early view .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jce.16117</ArticleId><ArticleId IdType="pubmed">37877234</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunning W.T., 3rd, Kvale H., Kramer P.M., Karabin B.L., Grubb B.P. Postural orthostatic tachycardia syndrome is associated with elevated g-protein coupled receptor autoantibodies. J. Am. Heart Assoc. 2019;8:e013602. doi: 10.1161/JAHA.119.013602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.119.013602</ArticleId><ArticleId IdType="pmc">PMC6818019</ArticleId><ArticleId IdType="pubmed">31495251</ArticleId></ArticleIdList></Reference><Reference><Citation>Blitshteyn S. Autoimmune markers and autoimmune disorders in patients with postural tachycardia syndrome (POTS) Lupus. 2015;24:1364&#x2013;1369. doi: 10.1177/0961203315587566.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203315587566</ArticleId><ArticleId IdType="pubmed">26038344</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Yu X., Liles C., Khan M., Vanderlinde-Wood M., Galloway A., Zillner C., Benbrook A., Reim S., Collier D., et al. Autoimmune basis for postural tachycardia syndrome. J. Am. Heart Assoc. 2014;3:e000755. doi: 10.1161/JAHA.113.000755.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.113.000755</ArticleId><ArticleId IdType="pmc">PMC3959717</ArticleId><ArticleId IdType="pubmed">24572257</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahan S., Tomljenovic L., Shoenfeld Y. Postural orthostatic tachycardia syndrome (POTS)&#x2014;A novel member of the autoimmune family. Lupus. 2016;25:339&#x2013;342. doi: 10.1177/0961203316629558.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203316629558</ArticleId><ArticleId IdType="pubmed">26846691</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernino S., Stiles L.E. Autoimmunity in postural orthostatic tachycardia syndrome: Current understanding. Auton. Neurosci. 2018;215:78&#x2013;82. doi: 10.1016/j.autneu.2018.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2018.04.005</ArticleId><ArticleId IdType="pubmed">29909990</ArticleId></ArticleIdList></Reference><Reference><Citation>Seeley M.C., Hooper M., Tan J., Wells R., Gallagher C., Lau D.H. Plasma exchange improves cognitive function in long-COVID-related postural orthostatic tachycardia syndrome and autoimmune neurological dysfunction. Am. J. Med. 2023;133:e157&#x2013;e159. doi: 10.1016/j.amjmed.2023.01.043.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2023.01.043</ArticleId><ArticleId IdType="pubmed">36828209</ArticleId></ArticleIdList></Reference><Reference><Citation>Shanks L., Jason L.A., Evans M., Brown A. Cognitive impairments associated with CFS and POTS. Front. Physiol. 2013;4:113. doi: 10.3389/fphys.2013.00113.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2013.00113</ArticleId><ArticleId IdType="pmc">PMC3655280</ArticleId><ArticleId IdType="pubmed">23720636</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold A.C., Haman K., Garland E.M., Raj V., Dupont W.D., Biaggioni I., Robertson D., Raj S.R. Cognitive dysfunction in postural tachycardia syndrome. Clin. Sci. 2015;128:39&#x2013;45. doi: 10.1042/CS20140251.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20140251</ArticleId><ArticleId IdType="pmc">PMC4161607</ArticleId><ArticleId IdType="pubmed">25001527</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj V., Opie M., Arnold A.C. Cognitive and psychological issues in postural tachycardia syndrome. Auton. Neurosci. 2018;215:46&#x2013;55. doi: 10.1016/j.autneu.2018.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2018.03.004</ArticleId><ArticleId IdType="pmc">PMC6160364</ArticleId><ArticleId IdType="pubmed">29628432</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoad A., Spickett G., Elliott J., Newton J. Postural orthostatic tachycardia syndrome is an under-recognized condition in chronic fatigue syndrome. QJM. 2008;101:961&#x2013;965. doi: 10.1093/qjmed/hcn123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcn123</ArticleId><ArticleId IdType="pubmed">18805903</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis I., Pairman J., Spickett G., Newton J.L. Clinical characteristics of a novel subgroup of chronic fatigue syndrome patients with postural orthostatic tachycardia syndrome. J. Intern. Med. 2013;273:501&#x2013;510. doi: 10.1111/joim.12022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.12022</ArticleId><ArticleId IdType="pubmed">23206180</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijs J., Ickmans K. Postural orthostatic tachycardia syndrome as a clinically important subgroup of chronic fatigue syndrome: Further evidence for central nervous system dysfunctioning. J. Intern. Med. 2013;273:498&#x2013;500. doi: 10.1111/joim.12034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.12034</ArticleId><ArticleId IdType="pubmed">23331489</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds G.K., Lewis D.P., Richardson A.M., Lidbury B.A. Comorbidity of postural orthostatic tachycardia syndrome and chronic fatigue syndrome in an Australian cohort. J. Intern. Med. 2014;275:409&#x2013;417. doi: 10.1111/joim.12161.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.12161</ArticleId><ArticleId IdType="pubmed">24206536</ArticleId></ArticleIdList></Reference><Reference><Citation>Wise S., Ross A., Brown A., Evans M., Jason L. An assessment of fatigue in patients with postural orthostatic tachycardia syndrome. J. Health Psychol. 2017;22:733&#x2013;742. doi: 10.1177/1359105315613624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1359105315613624</ArticleId><ArticleId IdType="pubmed">26537521</ArticleId></ArticleIdList></Reference><Reference><Citation>Boris J.R., Bernadzikowski T. Therapy for fatigue and cognitive dysfunction in postural orthostatic tachycardia syndrome. Cardiol. Young. 2018;28:1415&#x2013;1420. doi: 10.1017/S1047951118001415.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1047951118001415</ArticleId><ArticleId IdType="pubmed">30198448</ArticleId></ArticleIdList></Reference><Reference><Citation>Strassheim V., Welford J., Ballantine R., Newton J.L. Managing fatigue in postural tachycardia syndrome (PoTS): The newcastle approach. Auton. Neurosci. 2018;215:56&#x2013;61. doi: 10.1016/j.autneu.2018.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2018.02.003</ArticleId><ArticleId IdType="pubmed">29519643</ArticleId></ArticleIdList></Reference><Reference><Citation>Astudillo L., Laure A., Fabry V., Pugnet G., Maury P., Labrunee M., Sailler L., Pavy-Le Traon A. Postural tachycardia syndrome (PoTS): An up-to-date. Rev. Med. Interne. 2018;39:627&#x2013;634. doi: 10.1016/j.revmed.2018.04.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.revmed.2018.04.017</ArticleId><ArticleId IdType="pubmed">29909001</ArticleId></ArticleIdList></Reference><Reference><Citation>Blitshteyn S., Fedorowski A. The risks of POTS after COVID-19 vaccination and SARS-CoV-2 infection: More studies are needed. Nat. Rev. Cardiol. 2022;1:1119&#x2013;1120. doi: 10.1038/s44161-022-00180-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s44161-022-00180-z</ArticleId><ArticleId IdType="pubmed">39196162</ArticleId></ArticleIdList></Reference><Reference><Citation>Blitshteyn S. Human papillomavirus (HPV) vaccine safety concerning POTS, CRPS and related conditions. Clin. Auton. Res. 2020;30:181&#x2013;182. doi: 10.1007/s10286-019-00653-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-019-00653-5</ArticleId><ArticleId IdType="pubmed">31832903</ArticleId></ArticleIdList></Reference><Reference><Citation>Butts B.N., Fischer P.R., Mack K.J. Human papillomavirus vaccine and postural orthostatic tachycardia syndrome: A review of current literature. J. Child. Neurol. 2017;32:956&#x2013;965. doi: 10.1177/0883073817718731.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0883073817718731</ArticleId><ArticleId IdType="pubmed">28689455</ArticleId></ArticleIdList></Reference><Reference><Citation>Jefferson T., J&#xf8;rgensen L. Human papillomavirus vaccines, complex regional pain syndrome, postural orthostatic tachycardia syndrome, and autonomic dysfunction&#x2014;A review of the regulatory evidence from the European medicines agency. Indian J. Med. Ethics. 2017;2:30&#x2013;37. doi: 10.20529/IJME.2017.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.20529/IJME.2017.006</ArticleId><ArticleId IdType="pubmed">27867145</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomljenovic L., Colafrancesco S., Perricone C., Shoenfeld Y. Postural orthostatic tachycardia with chronic fatigue after HPV vaccination as part of the &#x201c;autoimmune/auto-inflammatory syndrome induced by adjuvants&#x201d;: Case report and literature review. J. Investig. Med. High Impact Case Rep. 2014;2:2324709614527812. doi: 10.1177/2324709614527812.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2324709614527812</ArticleId><ArticleId IdType="pmc">PMC4528866</ArticleId><ArticleId IdType="pubmed">26425598</ArticleId></ArticleIdList></Reference><Reference><Citation>Tv P., Tran T.T., Hao H.T., Hau N.T.H., Jain N., Reinis A. Postural orthostatic tachycardia syndrome-like symptoms following COVID-19 vaccination: An overview of clinical literature. Hum. Antibodies. 2023;31:9&#x2013;17. doi: 10.3233/HAB-220013.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/HAB-220013</ArticleId><ArticleId IdType="pmc">PMC10357168</ArticleId><ArticleId IdType="pubmed">37248893</ArticleId></ArticleIdList></Reference><Reference><Citation>Arana J., Mba-Jonas A., Jankosky C., Lewis P., Moro P.L., Shimabukuro T.T., Cano M. Reports of postural orthostatic tachycardia syndrome after human papillomavirus vaccination in the vaccine adverse event reporting system. J. Adolesc. Health. 2017;61:577&#x2013;582. doi: 10.1016/j.jadohealth.2017.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jadohealth.2017.08.004</ArticleId><ArticleId IdType="pubmed">29061232</ArticleId></ArticleIdList></Reference><Reference><Citation>Barboi A., Gibbons C.H., Axelrod F., Benarroch E.E., Biaggioni I., Chapleau M.W., Chelimsky G., Chelimsky T., Cheshire W.P., Claydon V.E., et al. Human papillomavirus (HPV) vaccine and autonomic disorders: A position statement from the American autonomic society. Clin. Auton. Res. 2020;30:13&#x2013;18. doi: 10.1007/s10286-019-00608-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-019-00608-w</ArticleId><ArticleId IdType="pubmed">31475305</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunning W.T., 3rd, Stepkowski S.M., Kramer P.M., Karabin B.L., Grubb B.P. Inflammatory biomarkers in postural orthostatic tachycardia syndrome with elevated G-protein-coupled receptor autoantibodies. J. Clin. Med. 2021;10:623. doi: 10.3390/jcm10040623.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10040623</ArticleId><ArticleId IdType="pmc">PMC7914580</ArticleId><ArticleId IdType="pubmed">33562074</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathias C.J., Low D.A., Iodice V., Owens A.P., Kirbis M., Grahame R. Postural tachycardia syndrome&#x2014;Current experience and concepts. Nat. Rev. Neurol. 2011;8:22&#x2013;34. doi: 10.1038/nrneurol.2011.187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.187</ArticleId><ArticleId IdType="pubmed">22143364</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;em Y., Redfield S., Austin J.P., Akrami A. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. eClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahdi A., Lodin K., Reistam U., Fedorowski A., Nygren-Bonnier M., Runold M., Bruchfeld J., Desta L., Pernow J., Nickander J., et al. Microvasular dysfunction and reduced cardiac stress reactivity in postural orthostatic tachycardia associated with postacute COVID-19. Circ. Arrhythmia Electrophysiol. 2023;16:413&#x2013;414. doi: 10.1161/CIRCEP.123.011881.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCEP.123.011881</ArticleId><ArticleId IdType="pubmed">37334702</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansson M., Stahlberg M., Runold M., Nygren-Bonnier M., Nilsson J., Olshansky B., Bruchfeld J., Fedorowski A. Long-haul post-COVID-19 symptoms presenting as a variant of postural orthostatic tachycardia syndrome: The swedish experience. JACC Case Rep. 2021;3:573&#x2013;580. doi: 10.1016/j.jaccas.2021.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaccas.2021.01.009</ArticleId><ArticleId IdType="pmc">PMC7946344</ArticleId><ArticleId IdType="pubmed">33723532</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen C.L.M.C., Rowe P.C., Visser F.C. Orthostatic symptoms and reductions in cerebral blood flow in long-haul COVID-19 patients: Similarities with myalgic encephalomyelitis/chronic fatigue syndrome. Medicina. 2021;58:28. doi: 10.3390/medicina58010028.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58010028</ArticleId><ArticleId IdType="pmc">PMC8778312</ArticleId><ArticleId IdType="pubmed">35056336</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L.D., Duricka D.L. Stellate ganglion block reduces symptoms of long COVID: A case series. J. Neuroimmunol. 2022;362:577784. doi: 10.1016/j.jneuroim.2021.577784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2021.577784</ArticleId><ArticleId IdType="pmc">PMC8653406</ArticleId><ArticleId IdType="pubmed">34922127</ArticleId></ArticleIdList></Reference><Reference><Citation>Rigo S., Urechie V., Diedrich A., Okamoto L.E., Biaggioni I., Shibao C.A. Impaired parasympathetic function in long-COVID postural orthostatic tachycardia syndrome&#x2014;A case-control study. Bioelectron. Med. 2023;9:19. doi: 10.1186/s42234-023-00121-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s42234-023-00121-6</ArticleId><ArticleId IdType="pmc">PMC10481607</ArticleId><ArticleId IdType="pubmed">37670400</ArticleId></ArticleIdList></Reference><Reference><Citation>Seeley M.C., Gallagher C., Ong E., Langdon A., Chieng J., Bailey D., Page A., Lim H.S., Lau D.H. High incidence of autonomic dysfunction and postural orthostatic tachycardia syndrome in patients with long COVID: Implications for management and health care planning. Am. J. Med. 2023. in press .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2023.06.010</ArticleId><ArticleId IdType="pmc">PMC10307671</ArticleId><ArticleId IdType="pubmed">37391116</ArticleId></ArticleIdList></Reference><Reference><Citation>Amekran Y., Damoun N., El Hangouche A.J. Postural orthostatic tachycardia syndrome and post-acute COVID-19. Glob. Cardiol. Sci. Pract. 2022;2022:e202213. doi: 10.21542/gcsp.2022.13.</Citation><ArticleIdList><ArticleId IdType="doi">10.21542/gcsp.2022.13</ArticleId><ArticleId IdType="pmc">PMC9629292</ArticleId><ArticleId IdType="pubmed">36339677</ArticleId></ArticleIdList></Reference><Reference><Citation>Chadda K.R., Blakey E.E., Huang C.L., Jeevaratnam K. Long COVID-19 and postural orthostatic tachycardia syndrome&#x2014;Is dysautonomia to be blamed? Front. Cardiovasc. Med. 2022;9:860198. doi: 10.3389/fcvm.2022.860198.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.860198</ArticleId><ArticleId IdType="pmc">PMC8959615</ArticleId><ArticleId IdType="pubmed">35355961</ArticleId></ArticleIdList></Reference><Reference><Citation>Ormiston C.K., Swiatkiewicz I., Taub P.R. Postural orthostatic tachycardia syndrome as a sequela of COVID-19. Heart Rhythm. 2022;19:1880&#x2013;1889. doi: 10.1016/j.hrthm.2022.07.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.hrthm.2022.07.014</ArticleId><ArticleId IdType="pmc">PMC9287587</ArticleId><ArticleId IdType="pubmed">35853576</ArticleId></ArticleIdList></Reference><Reference><Citation>Diekman S., Chung T. Post-acute sequelae of SARS-CoV-2 syndrome presenting as postural orthostatic tachycardia syndrome. Clin. Exp. Emerg. Med. 2023;10:18&#x2013;25. doi: 10.15441/ceem.22.409.</Citation><ArticleIdList><ArticleId IdType="doi">10.15441/ceem.22.409</ArticleId><ArticleId IdType="pmc">PMC10090716</ArticleId><ArticleId IdType="pubmed">36718484</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez-Moyano E., Rodr&#xed;guez-Capit&#xe1;n J., Gait&#xe1;n Rom&#xe1;n D., Reyes Bueno J.A., Villalobos S&#xe1;nchez A., Espildora Hern&#xe1;ndez F., Gonz&#xe1;lez Angulo G.E., Molina Mora M.J., Thurnhofer-Hemsi K., Molina-Ramos A.I., et al. Postural orthostatic tachycardia syndrome and other related dysautonomic disorders after SARS-CoV-2 infection and after COVID-19 messenger RNA vaccination. Front. Neurol. 2023;14:1221518. doi: 10.3389/fneur.2023.1221518.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2023.1221518</ArticleId><ArticleId IdType="pmc">PMC10467287</ArticleId><ArticleId IdType="pubmed">37654428</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamal S.M., Landers D.B., Hollenberg S.M., Turi Z.G., Glotzer T.V., Tancredi J., Parrillo J.E. Prospective evaluation of autonomic dysfunction in post-acute sequela of COVID-19. J. Am. Coll. Cardiol. 2022;79:2325&#x2013;2330. doi: 10.1016/j.jacc.2022.03.357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2022.03.357</ArticleId><ArticleId IdType="pmc">PMC8976261</ArticleId><ArticleId IdType="pubmed">35381331</ArticleId></ArticleIdList></Reference><Reference><Citation>Minhas R., Bharadwaj A.S. COVID-19-induced postural orthostatic tachycardia syndrome and dysautonomia. Cureus. 2023;15:e40235. doi: 10.7759/cureus.40235.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.40235</ArticleId><ArticleId IdType="pmc">PMC10332885</ArticleId><ArticleId IdType="pubmed">37435242</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak P., Giannetti M.P., Weller E., Hamilton M.J., Mukerji S.S., Alabsi H.S., Systrom D., Marciano S.P., Felsenstein D., Mullally W.J., et al. Network autonomic analysis of post-acute sequelae of COVID-19 and postural tachycardia syndrome. Neurol. Sci. 2022;43:6627&#x2013;6638. doi: 10.1007/s10072-022-06423-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-022-06423-y</ArticleId><ArticleId IdType="pmc">PMC9517969</ArticleId><ArticleId IdType="pubmed">36169757</ArticleId></ArticleIdList></Reference><Reference><Citation>Sherif Z.A., Gomez C.R., Connors T.J., Henrich T.J., Reeves W.B., Force R.M.P.T. Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC) eLife. 2023;12:e86002. doi: 10.7554/eLife.86002.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.86002</ArticleId><ArticleId IdType="pmc">PMC10032659</ArticleId><ArticleId IdType="pubmed">36947108</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak P., Mukerji S.S., Alabsi H.S., Systrom D., Marciano S.P., Felsenstein D., Mullally W.J., Pilgrim D.M. Multisystem involvement in post-acute sequelae of coronavirus disease 19. Ann. Neurol. 2022;91:367&#x2013;379. doi: 10.1002/ana.26286.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26286</ArticleId><ArticleId IdType="pmc">PMC9011495</ArticleId><ArticleId IdType="pubmed">34952975</ArticleId></ArticleIdList></Reference><Reference><Citation>Takao M., Ohira M. Neurological post-acute sequelae of SARS-CoV-2 infection. Psychiatry Clin. Neurosci. 2023;77:72&#x2013;83. doi: 10.1111/pcn.13481.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/pcn.13481</ArticleId><ArticleId IdType="pmc">PMC9538807</ArticleId><ArticleId IdType="pubmed">36148558</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedorowski A., Sutton R. Autonomic dysfunction and postural orthostatic tachycardia syndrome in post-acute COVID-19 syndrome. Nat. Rev. Cardiol. 2023;20:281&#x2013;282. doi: 10.1038/s41569-023-00842-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-023-00842-w</ArticleId><ArticleId IdType="pmc">PMC9893964</ArticleId><ArticleId IdType="pubmed">36732397</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller B.R., Robinson-Papp J. Postural orthostatic tachycardia syndrome and migraine: A narrative review. Headache. 2022;62:792&#x2013;800. doi: 10.1111/head.14365.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/head.14365</ArticleId><ArticleId IdType="pubmed">35852052</ArticleId></ArticleIdList></Reference><Reference><Citation>Wekerle H. Epstein-barr virus sparks brain autoimmunity in multiple sclerosis. Nature. 2022;603:230&#x2013;232. doi: 10.1038/d41586-022-00382-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-022-00382-2</ArticleId><ArticleId IdType="pubmed">35169323</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurtzke J.F., Heltberg A. Multiple sclerosis in the faroe islands: An epitome. J. Clin. Epidemiol. 2001;54:1&#x2013;22. doi: 10.1016/S0895-4356(00)00268-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0895-4356(00)00268-7</ArticleId><ArticleId IdType="pubmed">11165464</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurtzke J.F. Epidemiology in multiple sclerosis: A pilgrim&#x2019;s progress. Brain. 2013;136:2904&#x2013;2917. doi: 10.1093/brain/awt220.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awt220</ArticleId><ArticleId IdType="pubmed">23983034</ArticleId></ArticleIdList></Reference><Reference><Citation>Poser C.M., Hibberd P.L. Analysis of the &#x2018;epidemic&#x2019; of multiple sclerosis in the faroe islands. II. Biostatistical aspects. Neuroepidemiology. 1988;7:181&#x2013;189. doi: 10.1159/000110153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000110153</ArticleId><ArticleId IdType="pubmed">3194043</ArticleId></ArticleIdList></Reference><Reference><Citation>Poser C.M., Hibberd P.L., Benedikz J., Gudmundsson G. Analysis of the &#x2018;epidemic&#x2019; of multiple sclerosis in the faroe islands. I. Clinical and epidemiological aspects. Neuroepidemiology. 1988;7:168&#x2013;180. doi: 10.1159/000110152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000110152</ArticleId><ArticleId IdType="pubmed">3194042</ArticleId></ArticleIdList></Reference><Reference><Citation>Adamec I., Lovric M., Zaper D., Barusic A.K., Bach I., Junakovic A., Mismas A., Habek M. Postural orthostatic tachycardia syndrome associated with multiple sclerosis. Auton. Neurosci. 2013;173:65&#x2013;68. doi: 10.1016/j.autneu.2012.11.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2012.11.009</ArticleId><ArticleId IdType="pubmed">23246200</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A.D., VanElzakker M.B. Long COVID or post-acute sequelae of COVID-19 (PASC): An overview of biological factors that may contribute to persistent symptoms. Front. Microbiol. 2021;12:698169. doi: 10.3389/fmicb.2021.698169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Altmann D.M., Whettlock E.M., Liu S., Arachchillage D.J., Boyton R.J. The immunology of long COVID. Nat. Rev. Immunol. 2023;23:618&#x2013;634. doi: 10.1038/s41577-023-00904-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-023-00904-7</ArticleId><ArticleId IdType="pubmed">37433988</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff A.L., Lipkin W.I. ME/CFS and long COVID share similar symptoms and biological abnormalities: Road map to the literature. Front. Med. 2023;10:1187163. doi: 10.3389/fmed.2023.1187163.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1187163</ArticleId><ArticleId IdType="pmc">PMC10278546</ArticleId><ArticleId IdType="pubmed">37342500</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryabkova V.A., Gavrilova N.Y., Fedotkina T.V., Churilov L.P., Shoenfeld Y. Myalgic encephalomyelitis/chronic fatigue syndrome and post-COVID syndrome: A common neuroimmune ground. Diagnostics. 2023;13:66. doi: 10.3390/diagnostics13010066.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics13010066</ArticleId><ArticleId IdType="pmc">PMC9818907</ArticleId><ArticleId IdType="pubmed">36611357</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen C.L.M.C., Visser F.C. The abnormal cardiac index and stroke volume index changes during a normal tilt table test in ME/CFS patients compared to healthy volunteers, are not related to deconditioning. J. Thromb. Circ. 2018;2018:108.</Citation></Reference><Reference><Citation>van Campen C., Rowe P.C., Visser F.C. Blood volume status in ME/CFS correlates with the presence or absence of orthostatic symptoms: Preliminary results. Front. Pediatr. 2018;6:352. doi: 10.3389/fped.2018.00352.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2018.00352</ArticleId><ArticleId IdType="pmc">PMC6262290</ArticleId><ArticleId IdType="pubmed">30525014</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman L., Bested A.C., Bonilla H.F., Chheda B.V., Chu L., Curtin J.M., Dempsey T.T., Dimmock M.E., Dowell T.G., Felsenstein D., et al. Myalgic encephalomyelitis/chronic fatigue syndrome: Essentials of diagnosis and management. Mayo Clin. Proc. 2021;96:2861&#x2013;2878. doi: 10.1016/j.mayocp.2021.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.07.004</ArticleId><ArticleId IdType="pubmed">34454716</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen C.L.M.C., Rowe P.C., Verheugt F.W.A., Visser F.C. Influence of end-tidal CO2 on cerebral blood flow during orthostatic stress in controls and adults with myalgic encephalomyelitis/chronic fatigue syndrome. Physiol. Rep. 2023;11:e15639. doi: 10.14814/phy2.15639.</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.15639</ArticleId><ArticleId IdType="pmc">PMC10492011</ArticleId><ArticleId IdType="pubmed">37688420</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen C., Verheugt F.W.A., Rowe P.C., Visser F.C. Orthostatic chronotropic incompetence in patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) IBRO Neurosci. Rep. 2023;15:1&#x2013;10. doi: 10.1016/j.ibneur.2023.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ibneur.2023.04.005</ArticleId><ArticleId IdType="pmc">PMC10250802</ArticleId><ArticleId IdType="pubmed">37303862</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunning W.T., Kramer P.M., Cichocki J.A., Karabin B.L., Khuder S.A., Grubb B.P. Platelet storage pool deficiency and elevated inflammatory biomarkers are prevalent in postural orthostatic tachycardia syndrome. Cells. 2022;11:774. doi: 10.3390/cells11050774.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11050774</ArticleId><ArticleId IdType="pmc">PMC8909348</ArticleId><ArticleId IdType="pubmed">35269395</ArticleId></ArticleIdList></Reference><Reference><Citation>Staff A.C., Redman C.W., Williams D., Leeson P., Moe K., Thilaganathan B., Magnus P., Steegers E.A., Tsigas E.Z., Ness R.B., et al. Pregnancy and long-term maternal cardiovascular health: Progress through harmonization of research cohorts and biobanks. Hypertension. 2016;67:251&#x2013;260. doi: 10.1161/HYPERTENSIONAHA.115.06357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.115.06357</ArticleId><ArticleId IdType="pubmed">26667417</ArticleId></ArticleIdList></Reference><Reference><Citation>Thilaganathan B., Kalafat E. Cardiovascular system in preeclampsia and beyond. Hypertension. 2019;73:522&#x2013;531. doi: 10.1161/HYPERTENSIONAHA.118.11191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.118.11191</ArticleId><ArticleId IdType="pmc">PMC6380450</ArticleId><ArticleId IdType="pubmed">30712425</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan K., Chojenta C., Tavener M., Smith A., Loxton D. Postural orthostatic tachycardia syndrome during pregnancy: A systematic review of the literature. Auton. Neurosci. 2018;215:106&#x2013;118. doi: 10.1016/j.autneu.2018.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2018.05.003</ArticleId><ArticleId IdType="pubmed">29784553</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan K., Smith A., Blitshteyn S. POTS and pregnancy: A review of literature and recommendations for evaluation and treatment. Int. J. Womens Health. 2022;14:1831&#x2013;1847. doi: 10.2147/IJWH.S366667.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJWH.S366667</ArticleId><ArticleId IdType="pmc">PMC9795856</ArticleId><ArticleId IdType="pubmed">36590760</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj S.R., Guzman J.C., Harvey P., Richer L., Schondorf R., Seifer C., Thibodeau-Jarry N., Sheldon R.S. Canadian cardiovascular society position statement on postural orthostatic tachycardia syndrome (POTS) and related disorders of chronic orthostatic intolerance. Can. J. Cardiol. 2020;36:357&#x2013;372. doi: 10.1016/j.cjca.2019.12.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cjca.2019.12.024</ArticleId><ArticleId IdType="pubmed">32145864</ArticleId></ArticleIdList></Reference><Reference><Citation>Zadourian A., Doherty T.A., Swiatkiewicz I., Taub P.R. Postural orthostatic tachycardia syndrome: Prevalence, pathophysiology, and management. Drugs. 2018;78:983&#x2013;994. doi: 10.1007/s40265-018-0931-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40265-018-0931-5</ArticleId><ArticleId IdType="pubmed">29943373</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordan R., Gwathmey J.K., Xie L.H. Autonomic and endocrine control of cardiovascular function. World J. Cardiol. 2015;7:204&#x2013;214. doi: 10.4330/wjc.v7.i4.204.</Citation><ArticleIdList><ArticleId IdType="doi">10.4330/wjc.v7.i4.204</ArticleId><ArticleId IdType="pmc">PMC4404375</ArticleId><ArticleId IdType="pubmed">25914789</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong R., Wheen P., Brandon L., Maree A., Kenny R.A. Heart rate: Control mechanisms, pathophysiology and assessment of the neurocardiac system in health and disease. QJM. 2022;115:806&#x2013;812. doi: 10.1093/qjmed/hcab016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcab016</ArticleId><ArticleId IdType="pubmed">33486521</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon P.M., Taha B.H., Dempsey J.A., Skatrud J.B., Iber C. Role of vagal feedback from the lung in hypoxic-induced tachycardia in humans. J. Appl. Physiol. 1995;78:1522&#x2013;1530. doi: 10.1152/jappl.1995.78.4.1522.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jappl.1995.78.4.1522</ArticleId><ArticleId IdType="pubmed">7615465</ArticleId></ArticleIdList></Reference><Reference><Citation>Faulhaber M., Gatterer H., Haider T., Linser T., Netzer N., Burtscher M. Heart rate and blood pressure responses during hypoxic cycles of a 3-week intermittent hypoxia breathing program in patients at risk for or with mild COPD. Int. J. Chronic Obstr. Pulm. Dis. 2015;10:339&#x2013;345. doi: 10.2147/COPD.S75749.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/COPD.S75749</ArticleId><ArticleId IdType="pmc">PMC4334311</ArticleId><ArticleId IdType="pubmed">25709428</ArticleId></ArticleIdList></Reference><Reference><Citation>Siebenmann C., Lundby C. Regulation of cardiac output in hypoxia. Scand. J. Med. Sci. Sports. 2015;25((Suppl. S4)):53&#x2013;59. doi: 10.1111/sms.12619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/sms.12619</ArticleId><ArticleId IdType="pubmed">26589118</ArticleId></ArticleIdList></Reference><Reference><Citation>Paleczny B., Seredynski R., Tubek S., Adamiec D., Ponikowski P., Ponikowska B. Hypoxic tachycardia is not a result of increased respiratory activity in healthy subjects. Exp. Physiol. 2019;104:476&#x2013;489. doi: 10.1113/EP087233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/EP087233</ArticleId><ArticleId IdType="pubmed">30672622</ArticleId></ArticleIdList></Reference><Reference><Citation>Joyce W., Wang T. Regulation of heart rate in vertebrates during hypoxia: A comparative overview. Acta Physiol. 2022;234:e13779. doi: 10.1111/apha.13779.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apha.13779</ArticleId><ArticleId IdType="pubmed">34995393</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D.B., Pretorius E. No effects without causes. The iron dysregulation and dormant microbes hypothesis for chronic, inflammatory diseases. Biol. Rev. 2018;93:1518&#x2013;1557. doi: 10.1111/brv.12407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/brv.12407</ArticleId><ArticleId IdType="pmc">PMC6055827</ArticleId><ArticleId IdType="pubmed">29575574</ArticleId></ArticleIdList></Reference><Reference><Citation>Deer R.R., Rock M.A., Vasilevsky N., Carmody L., Rando H., Anzalone A.J., Basson M.D., Bennett T.D., Bergquist T., Boudreau E.A., et al. Characterizing long COVID: Deep phenotype of a complex condition. eBioMedicine. 2021;74:103722. doi: 10.1016/j.ebiom.2021.103722.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103722</ArticleId><ArticleId IdType="pmc">PMC8613500</ArticleId><ArticleId IdType="pubmed">34839263</ArticleId></ArticleIdList></Reference><Reference><Citation>Reese J.T., Blau H., Casiraghi E., Bergquist T., Loomba J.J., Callahan T.J., Laraway B., Antonescu C., Coleman B., Gargano M., et al. Generalisable long COVID subtypes: Findings from the NIH N3C and recover programmes. eBioMedicine. 2023;87:104413. doi: 10.1016/j.ebiom.2022.104413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.104413</ArticleId><ArticleId IdType="pmc">PMC9769411</ArticleId><ArticleId IdType="pubmed">36563487</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J., Liu S. Proposed subtypes of post-COVID-19 syndrome (or long-COVID) and their respective potential therapies. Rev. Med. Virol. 2022;32:e2315. doi: 10.1002/rmv.2315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2315</ArticleId><ArticleId IdType="pubmed">34888989</ArticleId></ArticleIdList></Reference><Reference><Citation>Low P.A., Schondorf R., Rummans T.A. Why do patients have orthostatic symptoms in POTS? Clin. Auton. Res. 2001;11:223&#x2013;224. doi: 10.1007/BF02298952.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02298952</ArticleId><ArticleId IdType="pubmed">11710793</ArticleId></ArticleIdList></Reference><Reference><Citation>Plash W.B., Diedrich A., Biaggioni I., Garland E.M., Paranjape S.Y., Black B.K., Dupont W.D., Raj S.R. Diagnosing postural tachycardia syndrome: Comparison of tilt testing compared with standing haemodynamics. Clin. Sci. 2013;124:109&#x2013;114. doi: 10.1042/CS20120276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20120276</ArticleId><ArticleId IdType="pmc">PMC3478101</ArticleId><ArticleId IdType="pubmed">22931296</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak P. Cerebral blood flow, heart rate, and blood pressure patterns during the tilt test in common orthostatic syndromes. Neurosci. J. 2016;2016:6127340. doi: 10.1155/2016/6127340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/6127340</ArticleId><ArticleId IdType="pmc">PMC4972931</ArticleId><ArticleId IdType="pubmed">27525257</ArticleId></ArticleIdList></Reference><Reference><Citation>Aponte-Becerra L., Novak P. Tilt test: A review. J. Clin. Neurophysiol. 2021;38:279&#x2013;286. doi: 10.1097/WNP.0000000000000625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WNP.0000000000000625</ArticleId><ArticleId IdType="pubmed">34009851</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheshire W.P., Jr., Goldstein D.S. Autonomic uprising: The tilt table test in autonomic medicine. Clin. Auton. Res. 2019;29:215&#x2013;230. doi: 10.1007/s10286-019-00598-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-019-00598-9</ArticleId><ArticleId IdType="pmc">PMC8897774</ArticleId><ArticleId IdType="pubmed">30838497</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart J.M., Visintainer P., Medow M.S. Standing tests lack reliability to diagnose all adolescents who have postural tachycardia syndrome. Clin. Auton. Res. 2023;33:899&#x2013;901. doi: 10.1007/s10286-023-00971-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-023-00971-9</ArticleId><ArticleId IdType="pubmed">37535202</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen M.E.V., Williams T.R., Gordon C., Chamberlain-Webber R., Sutton R. The normal response to prolonged passive head up tilt testing. Heart. 2000;84:509&#x2013;514. doi: 10.1136/heart.84.5.509.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/heart.84.5.509</ArticleId><ArticleId IdType="pmc">PMC1729464</ArticleId><ArticleId IdType="pubmed">11040011</ArticleId></ArticleIdList></Reference><Reference><Citation>Purkayastha S., Sorond F. Transcranial doppler ultrasound: Technique and application. Semin. Neurol. 2012;32:411&#x2013;420. doi: 10.1055/s-0032-1331812.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0032-1331812</ArticleId><ArticleId IdType="pmc">PMC3902805</ArticleId><ArticleId IdType="pubmed">23361485</ArticleId></ArticleIdList></Reference><Reference><Citation>Thijs R.D., Brignole M., Falup-Pecurariu C., Fanciulli A., Freeman R., Guaraldi P., Jordan J., Habek M., Hilz M., Traon A.P., et al. Recommendations for tilt table testing and other provocative cardiovascular autonomic tests in conditions that may cause transient loss of consciousness: Consensus statement of the European federation of autonomic societies (EFAS) endorsed by the American autonomic society (AAS) and the European academy of neurology (EAN) Clin. Auton. Res. 2021;31:369&#x2013;384. doi: 10.1007/s10286-020-00738-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-020-00738-6</ArticleId><ArticleId IdType="pmc">PMC8184725</ArticleId><ArticleId IdType="pubmed">33740206</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj S.R., Fedorowski A., Sheldon R.S. Diagnosis and management of postural orthostatic tachycardia syndrome. CMAJ. 2022;194:E378&#x2013;E385. doi: 10.1503/cmaj.211373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1503/cmaj.211373</ArticleId><ArticleId IdType="pmc">PMC8920526</ArticleId><ArticleId IdType="pubmed">35288409</ArticleId></ArticleIdList></Reference><Reference><Citation>Spahic J.M., Hamrefors V., Johansson M., Ricci F., Melander O., Sutton R., Fedorowski A. Malm&#xf6; POTS symptom score: Assessing symptom burden in postural orthostatic tachycardia syndrome. J. Intern. Med. 2023;293:91&#x2013;99. doi: 10.1111/joim.13566.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.13566</ArticleId><ArticleId IdType="pmc">PMC10087729</ArticleId><ArticleId IdType="pubmed">36111700</ArticleId></ArticleIdList></Reference><Reference><Citation>Benarroch E.E. Postural tachycardia syndrome: A heterogeneous and multifactorial disorder. Mayo Clin. Proc. 2012;87:1214&#x2013;1225. doi: 10.1016/j.mayocp.2012.08.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2012.08.013</ArticleId><ArticleId IdType="pmc">PMC3547546</ArticleId><ArticleId IdType="pubmed">23122672</ArticleId></ArticleIdList></Reference><Reference><Citation>Petelin Gadze Z., Bujan Kovac A., Adamec I., Milekic N., Sulentic V. Vagal nerve stimulation is beneficial in postural orthostatic tachycardia syndrome and epilepsy. Seizure. 2018;57:11&#x2013;13. doi: 10.1016/j.seizure.2018.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.seizure.2018.03.001</ArticleId><ArticleId IdType="pubmed">29529557</ArticleId></ArticleIdList></Reference><Reference><Citation>Diedrich A., Urechie V., Shiffer D., Rigo S., Minonzio M., Cairo B., Smith E.C., Okamoto L.E., Barbic F., Bisoglio A., et al. Transdermal auricular vagus stimulation for the treatment of postural tachycardia syndrome. Auton. Neurosci. 2021;236:102886. doi: 10.1016/j.autneu.2021.102886.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2021.102886</ArticleId><ArticleId IdType="pmc">PMC8939715</ArticleId><ArticleId IdType="pubmed">34634682</ArticleId></ArticleIdList></Reference><Reference><Citation>Benarroch E.E. &#x201c;Dysautonomia&#x201d;: A plea for precision. Clin. Auton. Res. 2021;31:27&#x2013;29. doi: 10.1007/s10286-020-00749-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10286-020-00749-3</ArticleId><ArticleId IdType="pubmed">33387098</ArticleId></ArticleIdList></Reference><Reference><Citation>Palma J.A., Norcliffe-Kaufmann L., Fuente-Mora C., Percival L., Mendoza-Santiesteban C., Kaufmann H. Current treatments in familial dysautonomia. Expert. Opin. Pharmacother. 2014;15:2653&#x2013;2671. doi: 10.1517/14656566.2014.970530.</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/14656566.2014.970530</ArticleId><ArticleId IdType="pmc">PMC4236240</ArticleId><ArticleId IdType="pubmed">25323828</ArticleId></ArticleIdList></Reference><Reference><Citation>Murga I., Aranburu L., Gargiulo P.A., Gomez Esteban J.C., Lafuente J.V. Clinical heterogeneity in ME/CFS. A way to understand long-COVID19 fatigue. Front. Psychiatry. 2021;12:735784. doi: 10.3389/fpsyt.2021.735784.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2021.735784</ArticleId><ArticleId IdType="pmc">PMC8542754</ArticleId><ArticleId IdType="pubmed">34707521</ArticleId></ArticleIdList></Reference><Reference><Citation>Carmona-Torre F., Minguez-Olaondo A., Lopez-Bravo A., Tijero B., Grozeva V., Walcker M., Azkune-Galparsoro H., Lopez de Munain A., Alcaide A.B., Quiroga J., et al. Dysautonomia in COVID-19 patients: A narrative review on clinical course, diagnostic and therapeutic strategies. Front. Neurol. 2022;13:886609. doi: 10.3389/fneur.2022.886609.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.886609</ArticleId><ArticleId IdType="pmc">PMC9198643</ArticleId><ArticleId IdType="pubmed">35720084</ArticleId></ArticleIdList></Reference><Reference><Citation>Bisaccia G., Ricci F., Recce V., Serio A., Iannetti G., Chahal A.A., Stahlberg M., Khanji M.Y., Fedorowski A., Gallina S. Post-acute sequelae of COVID-19 and cardiovascular autonomic dysfunction: What do we know? J. Cardiovasc. Dev. Dis. 2021;8:156. doi: 10.3390/jcdd8110156.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcdd8110156</ArticleId><ArticleId IdType="pmc">PMC8621226</ArticleId><ArticleId IdType="pubmed">34821709</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung T.H., Azar A. Autonomic nerve involvement in post-acute sequelae of SARS-CoV-2 syndrome (PASC) J. Clin. Med. 2022;12:73. doi: 10.3390/jcm12010073.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12010073</ArticleId><ArticleId IdType="pmc">PMC9821608</ArticleId><ArticleId IdType="pubmed">36614874</ArticleId></ArticleIdList></Reference><Reference><Citation>Marques K.C., Quaresma J.A.S., Falcao L.F.M. Cardiovascular autonomic dysfunction in &#x201c;long COVID&#x201d;: Pathophysiology, heart rate variability, and inflammatory markers. Front. Cardiovasc. Med. 2023;10:1256512. doi: 10.3389/fcvm.2023.1256512.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2023.1256512</ArticleId><ArticleId IdType="pmc">PMC10502909</ArticleId><ArticleId IdType="pubmed">37719983</ArticleId></ArticleIdList></Reference><Reference><Citation>Finsterer J. Small fiber neuropathy underlying dysautonomia in COVID-19 and in post-SARS-CoV-2 vaccination and long-COVID syndromes. Muscle Nerve. 2022;65:E31&#x2013;E32. doi: 10.1002/mus.27554.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.27554</ArticleId><ArticleId IdType="pmc">PMC9088382</ArticleId><ArticleId IdType="pubmed">35385125</ArticleId></ArticleIdList></Reference><Reference><Citation>Akt&#xfc;rk T., Turan Y., Tanik N., Karada&#x11f; M.E., Sacmaci H., Inan L.E. Vitamin D, vitamin D binding protein, vitamin D receptor levels and cardiac dysautonomia in patients with multiple sclerosis: A cross-sectional study. Arq. Neuro-Psiquiatr. 2019;77:848&#x2013;854. doi: 10.1590/0004-282x20190182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/0004-282x20190182</ArticleId><ArticleId IdType="pubmed">31939581</ArticleId></ArticleIdList></Reference><Reference><Citation>Foschi M., Giannini G., Merli E., Mancinelli L., Zenesini C., Viti B., Guaraldi P., Cortelli P., Lugaresi A. Frequency and characteristics of dysautonomic symptoms in multiple sclerosis: A cross-sectional double-center study with the validated Italian version of the composite autonomic symptom score-31. Neurol. Sci. 2021;42:1395&#x2013;1403. doi: 10.1007/s10072-020-04620-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-020-04620-1</ArticleId><ArticleId IdType="pmc">PMC7955976</ArticleId><ArticleId IdType="pubmed">32776288</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart J.M. Autonomic nervous system dysfunction in adolescents with postural orthostatic tachycardia syndrome and chronic fatigue syndrome is characterized by attenuated vagal baroreflex and potentiated sympathetic vasomotion. Pediatr. Res. 2000;48:218&#x2013;226. doi: 10.1203/00006450-200008000-00016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1203/00006450-200008000-00016</ArticleId><ArticleId IdType="pubmed">10926298</ArticleId></ArticleIdList></Reference><Reference><Citation>Naschitz J.E., Yeshurun D., Rosner I. Dysautonomia in chronic fatigue syndrome: Facts, hypotheses, implications. Med. Hypotheses. 2004;62:203&#x2013;206. doi: 10.1016/S0306-9877(03)00331-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0306-9877(03)00331-1</ArticleId><ArticleId IdType="pubmed">14962627</ArticleId></ArticleIdList></Reference><Reference><Citation>Bested A.C., Marshall L.M. Review of myalgic encephalomyelitis/chronic fatigue syndrome: An evidence-based approach to diagnosis and management by clinicians. Rev. Environ. Health. 2015;30:223&#x2013;249. doi: 10.1515/reveh-2015-0026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/reveh-2015-0026</ArticleId><ArticleId IdType="pubmed">26613325</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson M.J., Bahl J.S., Buckley J.D., Thomson R.L., Davison K. Evidence of altered cardiac autonomic regulation in myalgic encephalomyelitis/chronic fatigue syndrome: A systematic review and meta-analysis. Medicine. 2019;98:e17600. doi: 10.1097/MD.0000000000017600.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000017600</ArticleId><ArticleId IdType="pmc">PMC6824690</ArticleId><ArticleId IdType="pubmed">31651868</ArticleId></ArticleIdList></Reference><Reference><Citation>Murga Gandasegui I., Aranburu Laka L., Gargiulo P.&#xc1;., G&#xf3;mez-Esteban J.C., Lafuente S&#xe1;nchez J.V. Myalgic encephalomyelitis/chronic fatigue syndrome: A neurological entity? Medicina. 2021;57:1030. doi: 10.3390/medicina57101030.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57101030</ArticleId><ArticleId IdType="pmc">PMC8540700</ArticleId><ArticleId IdType="pubmed">34684066</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson M.J., Buckley J.D., Thomson R.L., Bellenger C.R., Davison K. Markers of cardiac autonomic function during consecutive day peak exercise tests in people with myalgic encephalomyelitis/chronic fatigue syndrome. Front. Physiol. 2021;12:771899. doi: 10.3389/fphys.2021.771899.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2021.771899</ArticleId><ArticleId IdType="pmc">PMC8713453</ArticleId><ArticleId IdType="pubmed">34970156</ArticleId></ArticleIdList></Reference><Reference><Citation>Renz-Polster H., Tremblay M.E., Bienzle D., Fischer J.E. The pathobiology of myalgic encephalomyelitis/chronic fatigue syndrome: The case for neuroglial failure. Front. Cell. Neurosci. 2022;16:888232. doi: 10.3389/fncel.2022.888232.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2022.888232</ArticleId><ArticleId IdType="pmc">PMC9124899</ArticleId><ArticleId IdType="pubmed">35614970</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavy-Le Traon A., Amarenco G., Duerr S., Kaufmann H., Lahrmann H., Shaftman S.R., Tison F., Wenning G.K., Goetz C.G., Poewe W., et al. The movement disorders task force review of dysautonomia rating scales in Parkinson&#x2019;s disease with regard to symptoms of orthostatic hypotension. Mov. Disord. 2011;26:1985&#x2013;1992. doi: 10.1002/mds.23742.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.23742</ArticleId><ArticleId IdType="pubmed">21547951</ArticleId></ArticleIdList></Reference><Reference><Citation>Krupp L.B. Fatigue in multiple sclerosis: Definition, pathophysiology and treatment. CNS Drugs. 2003;17:225&#x2013;234. doi: 10.2165/00023210-200317040-00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/00023210-200317040-00002</ArticleId><ArticleId IdType="pubmed">12665396</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen J., Barbera J., Shapiro C.M. Distinguishing sleepiness and fatigue: Focus on definition and measurement. Sleep. Med. Rev. 2006;10:63&#x2013;76. doi: 10.1016/j.smrv.2005.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smrv.2005.05.004</ArticleId><ArticleId IdType="pubmed">16376590</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi-Kwon S., Kim J.S. Poststroke fatigue: An emerging, critical issue in stroke medicine. Int. J. Stroke. 2011;6:328&#x2013;336. doi: 10.1111/j.1747-4949.2011.00624.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1747-4949.2011.00624.x</ArticleId><ArticleId IdType="pubmed">21745344</ArticleId></ArticleIdList></Reference><Reference><Citation>Kluger B.M., Herlofson K., Chou K.L., Lou J.S., Goetz C.G., Lang A.E., Weintraub D., Friedman J. Parkinson&#x2019;s disease-related fatigue: A case definition and recommendations for clinical research. Mov. Disord. 2016;31:625&#x2013;631. doi: 10.1002/mds.26511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.26511</ArticleId><ArticleId IdType="pmc">PMC4863238</ArticleId><ArticleId IdType="pubmed">26879133</ArticleId></ArticleIdList></Reference><Reference><Citation>Poulsen M.B., Skovb&#xf8;lling S.L., Kruuse C., Overgaard K., Rasmussen R.S. How to identify fatigue in stroke patients: An investigation of the post-stroke fatigue case definition validity. Top. Stroke Rehabil. 2020;27:369&#x2013;376. doi: 10.1080/10749357.2019.1704387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10749357.2019.1704387</ArticleId><ArticleId IdType="pubmed">31865869</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore Y., Serafimova T., Anderson N., King H., Richards A., Brigden A., Sinai P., Higgins J., Ascough C., Clery P., et al. Recovery from chronic fatigue syndrome: A systematic review-heterogeneity of definition limits study comparison. Arch. Dis. Child. 2021;106:1087&#x2013;1094. doi: 10.1136/archdischild-2020-320196.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2020-320196</ArticleId><ArticleId IdType="pmc">PMC8543221</ArticleId><ArticleId IdType="pubmed">33846138</ArticleId></ArticleIdList></Reference><Reference><Citation>Adibi I., Sanayei M., Tabibian F., Ramezani N., Pourmohammadi A., Azimzadeh K. Multiple sclerosis-related fatigue lacks a unified definition: A narrative review. J. Res. Med. Sci. 2022;27:24. doi: 10.4103/jrms.jrms_1401_20.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jrms.jrms_1401_20</ArticleId><ArticleId IdType="pmc">PMC8995308</ArticleId><ArticleId IdType="pubmed">35419061</ArticleId></ArticleIdList></Reference><Reference><Citation>Levesque A., Caru M., Duval M., Laverdiere C., Marjerrison S., Sultan S. Cancer-related fatigue: Scoping review to synthesize a definition for childhood cancer survivors. Support. Care Cancer. 2023;31:231. doi: 10.1007/s00520-023-07690-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00520-023-07690-x</ArticleId><ArticleId IdType="pubmed">36961617</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Bronkhorst P., Briedenhann S., Smit E., Franz R.C. Comparisons of the fibrin networks during pregnancy, nonpregnancy and pregnancy during dysfibrinogenaemia using the scanning electron microscope. Blood Coagul. Fibrinolysis. 2009;20:12&#x2013;16. doi: 10.1097/MBC.0b013e328322b429.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MBC.0b013e328322b429</ArticleId><ArticleId IdType="pubmed">20527721</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Oberholzer H.M., van der Spuy W.J., Meiring J.H. The changed ultrastructure of fibrin networks during use of oral contraception and hormone replacement. J. Thromb. Thrombolysis. 2010;30:502&#x2013;506. doi: 10.1007/s11239-010-0502-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-010-0502-4</ArticleId><ArticleId IdType="pubmed">20640484</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Steyn H., Engelbrecht M., Swanepoel A.C., Oberholzer H.M. Differences in fibrin fiber diameters in healthy individuals and thromboembolic ischemic stroke patients. Blood Coagul. Fibrinolysis. 2011;22:696&#x2013;700. doi: 10.1097/MBC.0b013e32834bdb32.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MBC.0b013e32834bdb32</ArticleId><ArticleId IdType="pubmed">22001525</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Vermeulen N., Bester J., Lipinski B., Kell D.B. A novel method for assessing the role of iron and its functional chelation in fibrin fibril formation: The use of scanning electron microscopy. Toxicol. Mech. Methods. 2013;23:352&#x2013;359. doi: 10.3109/15376516.2012.762082.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/15376516.2012.762082</ArticleId><ArticleId IdType="pubmed">23278212</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Mbotwe S., Bester J., Robinson C.J., Kell D.B. Acute induction of anomalous and amyloidogenic blood clotting by molecular amplification of highly substoichiometric levels of bacterial lipopolysaccharide. J. R. Soc. Interface. 2016;123:20160539. doi: 10.1098/rsif.2016.0539.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsif.2016.0539</ArticleId><ArticleId IdType="pmc">PMC5046953</ArticleId><ArticleId IdType="pubmed">27605168</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D.B., Pretorius E. Proteins behaving badly. Substoichiometric molecular control and amplification of the initiation and nature of amyloid fibril formation: Lessons from and for blood clotting. Prog. Biophys. Mol. Biol. 2017;123:16&#x2013;41. doi: 10.1016/j.pbiomolbio.2016.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pbiomolbio.2016.08.006</ArticleId><ArticleId IdType="pubmed">27554450</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Mbotwe S., Kell D.B. Lipopolysaccharide-binding protein (LBP) reverses the amyloid state of fibrin seen in plasma of type 2 diabetics with cardiovascular comorbidities. Sci. Rep. 2017;7:9680. doi: 10.1038/s41598-017-09860-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-09860-4</ArticleId><ArticleId IdType="pmc">PMC5574907</ArticleId><ArticleId IdType="pubmed">28851981</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Page M.J., Hendricks L., Nkosi N.B., Benson S.R., Kell D.B. Both lipopolysaccharide and lipoteichoic acids potently induce anomalous fibrin amyloid formation: Assessment with novel Amytracker&#x2122; stains. J. R. Soc. Interface. 2018;15:20170941. doi: 10.1098/rsif.2017.0941.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsif.2017.0941</ArticleId><ArticleId IdType="pmc">PMC5832738</ArticleId><ArticleId IdType="pubmed">29445039</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Page M.J., Mbotwe S., Kell D.B. Lipopolysaccharide-binding protein (LBP) can reverse the amyloid state of fibrin seen or induced in Parkinson&#x2019;s disease. PLoS ONE. 2018;13:e0192121. doi: 10.1371/journal.pone.0192121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0192121</ArticleId><ArticleId IdType="pmc">PMC5832207</ArticleId><ArticleId IdType="pubmed">29494603</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Bester J., Page M.J., Kell D.B. The potential of LPS-binding protein to reverse amyloid formation in plasma fibrin of individuals with Alzheimer-type dementia. Front. Aging Neurosci. 2018;10:257. doi: 10.3389/fnagi.2018.00257.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2018.00257</ArticleId><ArticleId IdType="pmc">PMC6113936</ArticleId><ArticleId IdType="pubmed">30186156</ArticleId></ArticleIdList></Reference><Reference><Citation>de Waal G.M., Engelbrecht L., Davis T., de Villiers W.J.S., Kell D.B., Pretorius E. Correlative light-electron microscopy detects lipopolysaccharide and its association with fibrin fibres in parkinson&#x2019;s disease, Alzheimer&#x2019;s disease and type 2 diabetes mellitus. Sci. Rep. 2018;8:16798. doi: 10.1038/s41598-018-35009-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-35009-y</ArticleId><ArticleId IdType="pmc">PMC6235901</ArticleId><ArticleId IdType="pubmed">30429533</ArticleId></ArticleIdList></Reference><Reference><Citation>Laubscher G.J., Lourens P.J., Venter C., Kell D.B., Pretorius E. TEG&#xae;, microclot and platelet mapping for guiding early management of severe COVID-19 coagulopathy. J. Clin. Med. 2021;10:5381. doi: 10.3390/jcm10225381.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10225381</ArticleId><ArticleId IdType="pmc">PMC8621180</ArticleId><ArticleId IdType="pubmed">34830660</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Kell D.B. Seminars in Thrombosis and Hemostasis. Thieme Medical Publishers, Inc.; New York, NY, USA: 2023. A perspective on how microscopy imaging of fibrinaloid microclots and platelet pathology may be applied in clinical investigations.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0043-1774796</ArticleId><ArticleId IdType="pmc">PMC11105946</ArticleId><ArticleId IdType="pubmed">37748515</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Bester J., Vermeulen N., Alummoottil S., Soma P., Buys A.V., Kell D.B. Poorly controlled type 2 diabetes is accompanied by significant morphological and ultrastructural changes in both erythrocytes and in thrombin-generated fibrin: Implications for diagnostics. Cardiovasc. Diabetol. 2015;13:30. doi: 10.1186/s12933-015-0192-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-015-0192-5</ArticleId><ArticleId IdType="pmc">PMC4364097</ArticleId><ArticleId IdType="pubmed">25848817</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Page M.J., Engelbrecht L., Ellis G.C., Kell D.B. Substantial fibrin amyloidogenesis in type 2 diabetes assessed using amyloid-selective fluorescent stains. Cardiovasc. Diabetol. 2017;16:141. doi: 10.1186/s12933-017-0624-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-017-0624-5</ArticleId><ArticleId IdType="pmc">PMC5668975</ArticleId><ArticleId IdType="pubmed">29096623</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Venter C., Laubscher G.J., Lourens P.J., Steenkamp J., Kell D.B. Prevalence of readily detected amyloid blood clots in &#x2018;unclotted&#x2019; type 2 diabetes mellitus and COVID-19 plasma: A preliminary report. Cardiovasc. Diabetol. 2020;19:193. doi: 10.1186/s12933-020-01165-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-020-01165-7</ArticleId><ArticleId IdType="pmc">PMC7670290</ArticleId><ArticleId IdType="pubmed">33203441</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D.B., Laubscher G.J., Pretorius E. A central role for amyloid fibrin microclots in long COVID/PASC: Origins and therapeutic implications. Biochem. J. 2022;479:537&#x2013;559. doi: 10.1042/BCJ20220016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20220016</ArticleId><ArticleId IdType="pmc">PMC8883497</ArticleId><ArticleId IdType="pubmed">35195253</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D.B., Pretorius E. The potential role of ischaemia-reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, long COVID and ME/CFS: Evidence, mechanisms, and therapeutic implications. Biochem. J. 2022;479:1653&#x2013;1708. doi: 10.1042/BCJ20220154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20220154</ArticleId><ArticleId IdType="pmc">PMC9484810</ArticleId><ArticleId IdType="pubmed">36043493</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D.B., Pretorius E. Are fibrinaloid microclots a cause of autoimmunity in long COVID and other post-infection diseases? Biochem. J. 2023;480:1217&#x2013;1240. doi: 10.1042/BCJ20230241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20230241</ArticleId><ArticleId IdType="pubmed">37584410</ArticleId></ArticleIdList></Reference><Reference><Citation>Kruger A., Vlok M., Turner S., Venter C., Laubscher G.J., Kell D.B., Pretorius E. Proteomics of fibrin amyloid microclots in long COVID/post-acute sequelae of COVID-19 (PASC) shows many entrapped pro-inflammatory molecules that may also contribute to a failed fibrinolytic system. Cardiovasc. Diabetol. 2022;21:190. doi: 10.1186/s12933-022-01623-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-022-01623-4</ArticleId><ArticleId IdType="pmc">PMC9491257</ArticleId><ArticleId IdType="pubmed">36131342</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Vlok M., Venter C., Bezuidenhout J.A., Laubscher G.J., Steenkamp J., Kell D.B. Persistent clotting protein pathology in long COVID/post-acute sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc. Diabetol. 2021;20:172. doi: 10.1186/s12933-021-01359-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-021-01359-7</ArticleId><ArticleId IdType="pmc">PMC8381139</ArticleId><ArticleId IdType="pubmed">34425843</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Venter C., Laubscher G.J., Kotze M.J., Oladejo S., Watson L.R., Rajaratnam K., Watson B.W., Kell D.B. Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with long COVID/post-acute sequelae of COVID-19 (PASC) Cardiovasc. Diabetol. 2022;21:148. doi: 10.1186/s12933-022-01579-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-022-01579-5</ArticleId><ArticleId IdType="pmc">PMC9356426</ArticleId><ArticleId IdType="pubmed">35933347</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner S., Khan M.A., Putrino D., Woodcock A., Kell D.B., Pretorius E. Long COVID: Pathophysiological factors and abnormal coagulation. Trends Endocrinol. Metab. 2023;34:321&#x2013;344. doi: 10.1016/j.tem.2023.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2023.03.002</ArticleId><ArticleId IdType="pmc">PMC10113134</ArticleId><ArticleId IdType="pubmed">37080828</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner S., Laubscher G.J., Khan M.A., Kell D.B., Pretorius E. Accelerating discovery: A novel flow cytometric method for detecting fibrin(ogen) amyloid microclots using long COVID as a model. Heliyon. 2023;9:e19605. doi: 10.1016/j.heliyon.2023.e19605.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2023.e19605</ArticleId><ArticleId IdType="pmc">PMC10558872</ArticleId><ArticleId IdType="pubmed">37809592</ArticleId></ArticleIdList></Reference><Reference><Citation>Grobbelaar L.M., Venter C., Vlok M., Ngoepe M., Laubscher G.J., Lourens P.J., Steenkamp J., Kell D.B., Pretorius E. SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: Implications for microclot formation in COVID-19. Biosci. Rep. 2021;41:BSR20210611. doi: 10.1042/BSR20210611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BSR20210611</ArticleId><ArticleId IdType="pmc">PMC8380922</ArticleId><ArticleId IdType="pubmed">34328172</ArticleId></ArticleIdList></Reference><Reference><Citation>Grobbelaar L.M., Kruger A., Venter C., Burger E.M., Laubscher G.J., Maponga T.G., Kotze M.J., Kwaan H.C., Miller J.B., Fulkerson D., et al. Relative hypercoagulopathy of the SARS-CoV-2 beta and delta variants when compared to the less severe omicron variants is related to TEG parameters, the extent of fibrin amyloid microclots, and the severity of clinical illness. Semin. Thromb. Haemost. 2022;48:858&#x2013;868. doi: 10.1055/s-0042-1756306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0042-1756306</ArticleId><ArticleId IdType="pubmed">36174604</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunes J.M., Kruger A., Proal A., Kell D.B., Pretorius E. The occurrence of hyperactivated platelets and fibrinaloid microclots in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) Pharmaceuticals. 2022;15:931. doi: 10.3390/ph15080931.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph15080931</ArticleId><ArticleId IdType="pmc">PMC9413879</ArticleId><ArticleId IdType="pubmed">36015078</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunes J.M., Kell D.B., Pretorius E. Cardiovascular and haematological pathology in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): A role for viruses. Blood Rev. 2023;60:101075. doi: 10.1016/j.blre.2023.101075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.blre.2023.101075</ArticleId><ArticleId IdType="pmc">PMC10027292</ArticleId><ArticleId IdType="pubmed">36963989</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell D.B., Pretorius E. The simultaneous occurrence of both hypercoagulability and hypofibrinolysis in blood and serum during systemic inflammation, and the roles of iron and fibrin(ogen) Integr. Biol. 2015;7:24&#x2013;52. doi: 10.1039/c4ib00173g.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c4ib00173g</ArticleId><ArticleId IdType="pubmed">25335120</ArticleId></ArticleIdList></Reference><Reference><Citation>Oaklander A.L., Mills A.J., Kelley M., Toran L.S., Smith B., Dalakas M.C., Nath A. Peripheral neuropathy evaluations of patients with prolonged long COVID. Neurol.-Neuroimmunol. Neuroinflamm. 2022;9:e1146. doi: 10.1212/NXI.0000000000001146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000001146</ArticleId><ArticleId IdType="pmc">PMC8889896</ArticleId><ArticleId IdType="pubmed">35232750</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Venter C., Laubscher G.J., Lourens P.J., Steenkamp J., Kell D.B. Prevalence of amyloid blood clots in COVID-19 plasma. medRxiv. 2020 doi: 10.1101/2020.07.28.20163543.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.07.28.20163543</ArticleId><ArticleId IdType="pmc">PMC7670290</ArticleId><ArticleId IdType="pubmed">33203441</ArticleId></ArticleIdList></Reference><Reference><Citation>Safavi F., Gustafson L., Walitt B., Lehky T., Dehbashi S., Wiebold A., Mina Y., Shin S., Pan B., Polydefkis M., et al. Neuropathic symptoms with SARS-CoV-2 vaccination. medRxiv. 2022 doi: 10.1101/2022.05.16.22274439.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.05.16.22274439</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C. Could SARS-CoV-2 spike protein be responsible for long-COVID syndrome? Mol. Neurobiol. 2022;59:1850&#x2013;1861. doi: 10.1007/s12035-021-02696-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-021-02696-0</ArticleId><ArticleId IdType="pmc">PMC8757925</ArticleId><ArticleId IdType="pubmed">35028901</ArticleId></ArticleIdList></Reference><Reference><Citation>Theoharides T.C., Kempuraj D. Role of SARS-CoV-2 spike-protein-induced activation of microglia and mast cells in the pathogenesis of neuro-COVID. Cells. 2023;12:688. doi: 10.3390/cells12050688.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells12050688</ArticleId><ArticleId IdType="pmc">PMC10001285</ArticleId><ArticleId IdType="pubmed">36899824</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy M., Nath A.K., Pal I., Dey S.G. Second sphere interactions in amyloidogenic diseases. Chem. Rev. 2022;122:12132&#x2013;12206. doi: 10.1021/acs.chemrev.1c00941.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.chemrev.1c00941</ArticleId><ArticleId IdType="pubmed">35471949</ArticleId></ArticleIdList></Reference><Reference><Citation>Janson J., Ashley R.H., Harrison D., McIntyre S., Butler P.C. The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. Diabetes. 1999;48:491&#x2013;498. doi: 10.2337/diabetes.48.3.491.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/diabetes.48.3.491</ArticleId><ArticleId IdType="pubmed">10078548</ArticleId></ArticleIdList></Reference><Reference><Citation>Engel M.F.M., Khemt&#xe9;mourian L., Kleijer C.C., Meeldijk H.J.D., Jacobs J., Verkleij A.J., de Kruijff B., Killian J.A., Hoppener J.W.M. Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane. Proc. Natl. Acad. Sci. USA. 2008;105:6033&#x2013;6038. doi: 10.1073/pnas.0708354105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0708354105</ArticleId><ArticleId IdType="pmc">PMC2329711</ArticleId><ArticleId IdType="pubmed">18408164</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman R., Pellarin R., Caflisch A. Amyloid aggregation on lipid bilayers and its impact on membrane permeability. J. Mol. Biol. 2009;387:407&#x2013;415. doi: 10.1016/j.jmb.2008.12.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2008.12.036</ArticleId><ArticleId IdType="pubmed">19133272</ArticleId></ArticleIdList></Reference><Reference><Citation>Butterfield S.M., Lashuel H.A. Amyloidogenic protein-membrane interactions: Mechanistic insight from model systems. Angew. Chem. Int. Ed. Engl. 2010;49:5628&#x2013;5654. doi: 10.1002/anie.200906670.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.200906670</ArticleId><ArticleId IdType="pubmed">20623810</ArticleId></ArticleIdList></Reference><Reference><Citation>Sciacca M.F.M., Brender J.R., Lee D.K., Ramamoorthy A. Phosphatidylethanolamine enhances amyloid fiber-dependent membrane fragmentation. Biochemistry. 2012;51:7676&#x2013;7684. doi: 10.1021/bi3009888.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi3009888</ArticleId><ArticleId IdType="pmc">PMC3464957</ArticleId><ArticleId IdType="pubmed">22970795</ArticleId></ArticleIdList></Reference><Reference><Citation>Sciacca M.F.M., Kotler S.A., Brender J.R., Chen J., Lee D.K., Ramamoorthy A. Two-step mechanism of membrane disruption by abeta through membrane fragmentation and pore formation. Biophys. J. 2012;103:702&#x2013;710. doi: 10.1016/j.bpj.2012.06.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2012.06.045</ArticleId><ArticleId IdType="pmc">PMC3443794</ArticleId><ArticleId IdType="pubmed">22947931</ArticleId></ArticleIdList></Reference><Reference><Citation>Relini A., Marano N., Gliozzi A. Misfolding of amyloidogenic proteins and their interactions with membranes. Biomolecules. 2013;4:20&#x2013;55. doi: 10.3390/biom4010020.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom4010020</ArticleId><ArticleId IdType="pmc">PMC4030986</ArticleId><ArticleId IdType="pubmed">24970204</ArticleId></ArticleIdList></Reference><Reference><Citation>Sciacca M.F.M., Milardi D., Messina G.M.L., Marletta G., Brender J.R., Ramamoorthy A., La Rosa C. Cations as switches of amyloid-mediated membrane disruption mechanisms: Calcium and IAPP. Biophys. J. 2013;104:173&#x2013;184. doi: 10.1016/j.bpj.2012.11.3811.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2012.11.3811</ArticleId><ArticleId IdType="pmc">PMC3540246</ArticleId><ArticleId IdType="pubmed">23332070</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang H., Arce F.T., Ramachandran S., Kagan B.L., Lal R., Nussinov R. Disordered amyloidogenic peptides may insert into the membrane and assemble into common cyclic structural motifs. Chem. Soc. Rev. 2014;43:6750&#x2013;6764. doi: 10.1039/C3CS60459D.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C3CS60459D</ArticleId><ArticleId IdType="pmc">PMC4143503</ArticleId><ArticleId IdType="pubmed">24566672</ArticleId></ArticleIdList></Reference><Reference><Citation>Ow S.Y., Dunstan D.E. A brief overview of amyloids and Alzheimer&#x2019;s disease. Protein Sci. 2014;23:1315&#x2013;1331. doi: 10.1002/pro.2524.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pro.2524</ArticleId><ArticleId IdType="pmc">PMC4286994</ArticleId><ArticleId IdType="pubmed">25042050</ArticleId></ArticleIdList></Reference><Reference><Citation>Relini A., Marano N., Gliozzi A. Probing the interplay between amyloidogenic proteins and membranes using lipid monolayers and bilayers. Adv. Colloid Interface Sci. 2014;207:81&#x2013;92. doi: 10.1016/j.cis.2013.10.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cis.2013.10.015</ArticleId><ArticleId IdType="pubmed">24200086</ArticleId></ArticleIdList></Reference><Reference><Citation>Caillon L., Hoffmann A.R., Botz A., Khemtemourian L. Molecular structure, membrane interactions, and toxicity of the islet amyloid polypeptide in type 2 diabetes mellitus. J. Diabetes Res. 2016;2016:5639875. doi: 10.1155/2016/5639875.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/5639875</ArticleId><ArticleId IdType="pmc">PMC4655289</ArticleId><ArticleId IdType="pubmed">26636105</ArticleId></ArticleIdList></Reference><Reference><Citation>Bode D.C., Baker M.D., Viles J.H. Ion channel formation by amyloid-beta42 oligomers but not amyloid-beta40 in cellular membranes. J. Biol. Chem. 2017;292:1404&#x2013;1413. doi: 10.1074/jbc.M116.762526.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M116.762526</ArticleId><ArticleId IdType="pmc">PMC5270483</ArticleId><ArticleId IdType="pubmed">27927987</ArticleId></ArticleIdList></Reference><Reference><Citation>Malishev R., Shaham-Niv S., Nandi S., Kolusheva S., Gazit E., Jelinek R. Bacoside-A, an indian traditional-medicine substance, inhibits beta-amyloid cytotoxicity, fibrillation, and membrane interactions. ACS Chem. Neurosci. 2017;8:884&#x2013;891. doi: 10.1021/acschemneuro.6b00438.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.6b00438</ArticleId><ArticleId IdType="pubmed">28094495</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng B., Li Y., Ma L., Wang Z., Petersen R.B., Zheng L., Chen Y., Huang K. Interaction between amyloidogenic proteins and biomembranes in protein misfolding diseases: Mechanisms, contributors, and therapy. Biochim. Biophys. Acta Biomembr. 2018;1860:1876&#x2013;1888. doi: 10.1016/j.bbamem.2018.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamem.2018.02.013</ArticleId><ArticleId IdType="pubmed">29466701</ArticleId></ArticleIdList></Reference><Reference><Citation>Rawat A., Langen R., Varkey J. Membranes as modulators of amyloid protein misfolding and target of toxicity. Biochim. Biophys. Acta Biomembr. 2018;1860:1863&#x2013;1875. doi: 10.1016/j.bbamem.2018.04.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamem.2018.04.011</ArticleId><ArticleId IdType="pmc">PMC6203680</ArticleId><ArticleId IdType="pubmed">29702073</ArticleId></ArticleIdList></Reference><Reference><Citation>Sciacca M.F.M., Chillemi R., Sciuto S., Greco V., Messineo C., Kotler S.A., Lee D.K., Brender J.R., Ramamoorthy A., La Rosa C., et al. A blend of two resveratrol derivatives abolishes hIAPP amyloid growth and membrane damage. Biochim. Biophys. Acta Biomembr. 2018;1860:1793&#x2013;1802. doi: 10.1016/j.bbamem.2018.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamem.2018.03.012</ArticleId><ArticleId IdType="pubmed">29555190</ArticleId></ArticleIdList></Reference><Reference><Citation>Younan N.D., Chen K.F., Rose R.S., Crowther D.C., Viles J.H. Prion protein stabilizes amyloid-beta (abeta) oligomers and enhances abeta neurotoxicity in a Drosophila model of Alzheimer&#x2019;s disease. J. Biol. Chem. 2018;293:13090&#x2013;13099. doi: 10.1074/jbc.RA118.003319.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.003319</ArticleId><ArticleId IdType="pmc">PMC6109938</ArticleId><ArticleId IdType="pubmed">29887525</ArticleId></ArticleIdList></Reference><Reference><Citation>Bode D.C., Freeley M., Nield J., Palma M., Viles J.H. Amyloid-beta oligomers have a profound detergent-like effect on lipid membrane bilayers, imaged by atomic force and electron microscopy. J. Biol. Chem. 2019;294:7566&#x2013;7572. doi: 10.1074/jbc.AC118.007195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.AC118.007195</ArticleId><ArticleId IdType="pmc">PMC6514634</ArticleId><ArticleId IdType="pubmed">30948512</ArticleId></ArticleIdList></Reference><Reference><Citation>Malishev R., Kolusheva S., Jelinek R. Vesicle-based assays to study membrane interactions of amyloid peptides. Methods Mol. Biol. 2019;1873:39&#x2013;51. doi: 10.1007/978-1-4939-8820-4_3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-8820-4_3</ArticleId><ArticleId IdType="pubmed">30341602</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y.R., Liu R.T. The toxicity and polymorphism of beta-amyloid oligomers. Int. J. Mol. Sci. 2020;21:4477. doi: 10.3390/ijms21124477.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21124477</ArticleId><ArticleId IdType="pmc">PMC7352971</ArticleId><ArticleId IdType="pubmed">32599696</ArticleId></ArticleIdList></Reference><Reference><Citation>Sciacca M.F.M., La Rosa C., Milardi D. Amyloid-mediated mechanisms of membrane disruption. Biophysica. 2021;1:137&#x2013;156. doi: 10.3390/biophysica1020011.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biophysica1020011</ArticleId><ArticleId IdType="pmc">PMC3540246</ArticleId><ArticleId IdType="pubmed">23332070</ArticleId></ArticleIdList></Reference><Reference><Citation>Tempra C., Scollo F., Pannuzzo M., Lolicato F., La Rosa C. A unifying framework for amyloid-mediated membrane damage: The lipid-chaperone hypothesis. Biochim. Biophys. Acta Proteins Proteom. 2022;1870:140767. doi: 10.1016/j.bbapap.2022.140767.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbapap.2022.140767</ArticleId><ArticleId IdType="pubmed">35144022</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma L., Li X., Petersen R.B., Peng A., Huang K. Probing the interactions between amyloidogenic proteins and bio-membranes. Biophys. Chem. 2023;296:106984. doi: 10.1016/j.bpc.2023.106984.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpc.2023.106984</ArticleId><ArticleId IdType="pubmed">36889133</ArticleId></ArticleIdList></Reference><Reference><Citation>Viles J.H. Imaging amyloid-beta membrane interactions: Ion-channel pores and lipid-bilayer permeability in Alzheimer&#x2019;s disease. Angew. Chem. Int. Ed. Engl. 2023;62:e202215785. doi: 10.1002/anie.202215785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.202215785</ArticleId><ArticleId IdType="pmc">PMC10953358</ArticleId><ArticleId IdType="pubmed">36876912</ArticleId></ArticleIdList></Reference><Reference><Citation>Busciglio J., Lorenzo A., Yankner B.A. Methodological variables in the assessment of beta amyloid neurotoxicity. Neurobiol. Aging. 1992;13:609&#x2013;612. doi: 10.1016/0197-4580(92)90065-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0197-4580(92)90065-6</ArticleId><ArticleId IdType="pubmed">1461350</ArticleId></ArticleIdList></Reference><Reference><Citation>Ono K., Condron M.M., Teplow D.B. Structure-neurotoxicity relationships of amyloid beta-protein oligomers. Proc. Natl. Acad. Sci. USA. 2009;106:14745&#x2013;14750. doi: 10.1073/pnas.0905127106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0905127106</ArticleId><ArticleId IdType="pmc">PMC2736424</ArticleId><ArticleId IdType="pubmed">19706468</ArticleId></ArticleIdList></Reference><Reference><Citation>Broersen K., Rousseau F., Schymkowitz J. The culprit behind amyloid beta peptide related neurotoxicity in Alzheimer&#x2019;s disease: Oligomer size or conformation? Alzheimers Res. Ther. 2010;2:12. doi: 10.1186/alzrt36.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/alzrt36</ArticleId><ArticleId IdType="pmc">PMC2949586</ArticleId><ArticleId IdType="pubmed">20642866</ArticleId></ArticleIdList></Reference><Reference><Citation>Malchiodi-Albedi F., Paradisi S., Matteucci A., Frank C., Diociaiuti M. Amyloid oligomer neurotoxicity, calcium dysregulation, and lipid rafts. Int. J. Alzheimers Dis. 2011;2011:906964. doi: 10.4061/2011/906964.</Citation><ArticleIdList><ArticleId IdType="doi">10.4061/2011/906964</ArticleId><ArticleId IdType="pmc">PMC3038657</ArticleId><ArticleId IdType="pubmed">21331330</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith L.M., Strittmatter S.M. Binding sites for amyloid-beta oligomers and synaptic toxicity. Cold Spring Harb. Perspect. Med. 2017;7:a024075. doi: 10.1101/cshperspect.a024075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a024075</ArticleId><ArticleId IdType="pmc">PMC5411685</ArticleId><ArticleId IdType="pubmed">27940601</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanokashira D., Mamada N., Yamamoto F., Taniguchi K., Tamaoka A., Lakshmana M.K., Araki W. The neurotoxicity of amyloid beta-protein oligomers is reversible in a primary neuron model. Mol. Brain. 2017;10:4. doi: 10.1186/s13041-016-0284-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-016-0284-5</ArticleId><ArticleId IdType="pmc">PMC5282621</ArticleId><ArticleId IdType="pubmed">28137266</ArticleId></ArticleIdList></Reference><Reference><Citation>Kepp K.P., Robakis N.K., Hoilund-Carlsen P.F., Sensi S.L., Vissel B. The amyloid cascade hypothesis: An updated critical review. Brain. 2023;146:3969&#x2013;3990. doi: 10.1093/brain/awad159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awad159</ArticleId><ArticleId IdType="pubmed">37183523</ArticleId></ArticleIdList></Reference><Reference><Citation>Killingley B., Mann A.J., Kalinova M., Boyers A., Goonawardane N., Zhou J., Lindsell K., Hare S.S., Brown J., Frise R., et al. Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults. Nat. Med. 2022;28:1031&#x2013;1041. doi: 10.1038/s41591-022-01780-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01780-9</ArticleId><ArticleId IdType="pubmed">35361992</ArticleId></ArticleIdList></Reference><Reference><Citation>Appelman B., Charlton B.T., Goulding R.P., Kerkhoff T.J., Breedveld E.A., Noort W., Offringa C., Bloemers F.W., van Weeghel M., Schomakers B.V., et al. Muscle abnormalities worsen after postexertional malaise in long COVID. Nat. Commun. 2024;15:17. doi: 10.1038/s41467-023-44432-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-44432-3</ArticleId><ArticleId IdType="pmc">PMC10766651</ArticleId><ArticleId IdType="pubmed">38177128</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassiliou A.G., Jahaj E., Ilias I., Markaki V., Malachias S., Vrettou C., Ischaki E., Mastora Z., Douka E., Keskinidou C., et al. Lactate kinetics reflect organ dysfunction and are associated with adverse outcomes in intensive care unit patients with COVID-19 pneumonia: Preliminary results from a greek single-centre study. Metabolites. 2020;10:386. doi: 10.3390/metabo10100386.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo10100386</ArticleId><ArticleId IdType="pmc">PMC7599563</ArticleId><ArticleId IdType="pubmed">32998323</ArticleId></ArticleIdList></Reference><Reference><Citation>Iepsen U.W., Plovsing R.R., Tjelle K., Foss N.B., Meyhoff C.S., Ryrs&#xf8; C.K., Berg R.M.G., Secher N.H. The role of lactate in sepsis and COVID-19: Perspective from contracting skeletal muscle metabolism. Exp. Physiol. 2021;107:665&#x2013;673. doi: 10.1113/EP089474.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/EP089474</ArticleId><ArticleId IdType="pmc">PMC8239768</ArticleId><ArticleId IdType="pubmed">34058787</ArticleId></ArticleIdList></Reference><Reference><Citation>Nechipurenko Y.D., Semyonov D.A., Lavrinenko I.A., Lagutkin D.A., Generalov E.A., Zaitceva A.Y., Matveeva O.V., Yegorov Y.E. The role of acidosis in the pathogenesis of severe forms of COVID-19. Biology. 2021;10:852. doi: 10.3390/biology10090852.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology10090852</ArticleId><ArticleId IdType="pmc">PMC8469745</ArticleId><ArticleId IdType="pubmed">34571729</ArticleId></ArticleIdList></Reference><Reference><Citation>Carpen&#xe8; G., Onorato D., Nocini R., Fortunato G., Rizk J.G., Henry B.M., Lippi G. Blood lactate concentration in COVID-19: A systematic literature review. Clin. Chem. Lab. Med. 2022;60:332&#x2013;337. doi: 10.1515/cclm-2021-1115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/cclm-2021-1115</ArticleId><ArticleId IdType="pubmed">34856090</ArticleId></ArticleIdList></Reference><Reference><Citation>de Boer E., Petrache I., Goldstein N.M., Olin J.T., Keith R.C., Modena B., Mohning M.P., Yunt Z.X., San-Millan I., Swigris J.J. Decreased fatty acid oxidation and altered lactate production during exercise in patients with post-acute COVID-19 syndrome. Am. J. Respir. Crit. Care Med. 2022;205:126&#x2013;129. doi: 10.1164/rccm.202108-1903LE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202108-1903LE</ArticleId><ArticleId IdType="pmc">PMC8865580</ArticleId><ArticleId IdType="pubmed">34665688</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Togt V., Rossman J.S. Hypothesis: Inflammatory acid-base disruption underpins long COVID. Front. Immunol. 2023;14:1150105. doi: 10.3389/fimmu.2023.1150105.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1150105</ArticleId><ArticleId IdType="pmc">PMC10140510</ArticleId><ArticleId IdType="pubmed">37122723</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutherford G., Manning P., Newton J.L. Understanding muscle dysfunction in chronic fatigue syndrome. J. Aging Res. 2016;2016:2497348. doi: 10.1155/2016/2497348.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/2497348</ArticleId><ArticleId IdType="pmc">PMC4779819</ArticleId><ArticleId IdType="pubmed">26998359</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Guerra P., Gonzalez-Ebsen A.C., Boonen S.E., Courraud J., Gregersen N., Mehlsen J., Palmfeldt J., Olsen R.K.J., Brinth L.S. Bioenergetic and proteomic profiling of immune cells in myalgic encephalomyelitis/chronic fatigue syndrome patients: An exploratory study. Biomolecules. 2021;11:961. doi: 10.3390/biom11070961.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom11070961</ArticleId><ArticleId IdType="pmc">PMC8301912</ArticleId><ArticleId IdType="pubmed">34209852</ArticleId></ArticleIdList></Reference><Reference><Citation>Natelson B.H., Vu D., Coplan J.D., Mao X., Blate M., Kang G., Soto E., Kapusuz T., Shungu D.C. Elevations of ventricular lactate levels occur in both chronic fatigue syndrome and fibromyalgia. Fatigue. 2017;5:15&#x2013;20. doi: 10.1080/21641846.2017.1280114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21641846.2017.1280114</ArticleId><ArticleId IdType="pmc">PMC5754037</ArticleId><ArticleId IdType="pubmed">29308330</ArticleId></ArticleIdList></Reference><Reference><Citation>Murrough J.W., Mao X., Collins K.A., Kelly C., Andrade G., Nestadt P., Levine S.M., Mathew S.J., Shungu D.C. Increased ventricular lactate in chronic fatigue syndrome measured by 1H MRS imaging at 3.0 T. II: Comparison with major depressive disorder. NMR Biomed. 2010;23:643&#x2013;650. doi: 10.1002/nbm.1512.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nbm.1512</ArticleId><ArticleId IdType="pubmed">20661876</ArticleId></ArticleIdList></Reference><Reference><Citation>Shungu D.C., Weiduschat N., Murrough J.W., Mao X., Pillemer S., Dyke J.P., Medow M.S., Natelson B.H., Stewart J.M., Mathew S.J. Increased ventricular lactate in chronic fatigue syndrome. III. Relationships to cortical glutathione and clinical symptoms implicate oxidative stress in disorder pathophysiology. NMR Biomed. 2012;25:1073&#x2013;1087. doi: 10.1002/nbm.2772.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nbm.2772</ArticleId><ArticleId IdType="pmc">PMC3896084</ArticleId><ArticleId IdType="pubmed">22281935</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>